论文部分内容阅读
目的观察1,6-二磷酸果糖联合黄芪注射液治疗病毒性心肌炎的疗效。方法两组均采用常规治疗,治疗组在此基础上加用1,6-二磷酸果糖100~250 mg/(kg.d)静脉滴注,以及黄芪注射液静脉滴注5~20 ml/次,每天1次,10 d为1个疗程,一般用2~3个疗程。结果治疗组总有效率达93%,高于对照组的75%。两组间比较差异有统计学意义(P<0.05);观察组心电图及心肌酶谱复常率(91%)优于对照组(70%),两组比较差异有统计学意义(P<0.05)。结论 1,6-二磷酸果糖联合黄芪注射液治疗病毒性心肌炎能改善临床症状,提高治愈率。
Objective To observe the efficacy of fructose-1,6-diphosphate combined with astragalus injection in the treatment of viral myocarditis. Methods Both groups were treated by conventional therapy. On the basis of this, the treatment group received intravenous drip of 100 ~ 250 mg / (kg · d) fructose 1,6 - diphosphate and 5 ~ 20 ml / time intravenous infusion of Astragalus membranaceus , 1 day, 10 d for a course of treatment, generally with 2 to 3 courses. Results The total effective rate in the treatment group was 93%, which was 75% higher than that in the control group. The difference between the two groups was statistically significant (P <0.05). The electrocardiogram and myocardial enzymes in the observation group (91%) were superior to the control group (70%), the difference was statistically significant (P <0.05 ). Conclusion Fructose-1,6-diphosphate combined with Astragalus injection in the treatment of viral myocarditis can improve the clinical symptoms and improve the cure rate.